Stroke Unit, Department of Neurology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Neurology. 2011 Oct 25;77(17):1599-604. doi: 10.1212/WNL.0b013e3182343387. Epub 2011 Oct 12.
To investigate the impact of the adjustment of initial intracerebral hemorrhage (ICH) volume by onset-to-imaging time (ultraearly hematoma growth [uHG]) on further hematoma enlargement and outcome in patients with acute ICH.
We studied 133 patients with acute (<6 hours) supratentorial ICH. Patients underwent baseline and 24-hour CT scans for ICH volume measurement, and a CT angiography (CTA) for the detection of the spot sign. We defined uHG as the relation between baseline ICH volume/onset-to-imaging time, hematoma growth (HG) as hematoma enlargement >33% or >6 mL at 24 hours, early neurologic deterioration (END) as increase ≥4 points in the NIH Stroke Scale score or death at 24 hours, and poor long-term outcome as modified Rankin Scale score >2 at 3 months.
The uHG was significantly faster in spot sign patients (p < 0.001), as well as in patients who experienced HG (p = 0.021), END (p < 0.001), 3-month mortality (p < 0.001), and poor long-term outcome (p < 0.001). The uHG improved the accuracy of baseline ICH volume in the prediction of END (sensitivity 93.1% vs 82.8%, specificity 85.3% vs 82.4%) and 3-month mortality (sensitivity 77.5% vs 70%, specificity 87.9% vs 84.6%). A uHG >10.2 mL/hour emerged as the most powerful predictor of HG (odds ratio [OR] 3.55, 95% confidence interval [CI] 1.39-9.07, p = 0.008), END (OR 70.22, 95% CI 14.63-337.03, p < 0.001), 3-month mortality (OR 16.96, 95% CI 5.32-54.03, p < 0.001), and poor long-term outcome (OR 6.19, 95% CI 1.32-28.98, p = 0.021).
The uHG represents a powerful and easy-to-use tool for improving the prediction of HG and outcome in patients with acute ICH.
探讨发病至影像学检查时间(超早期血肿增长[uHG])对急性脑出血患者进一步血肿扩大和结局的影响。
我们研究了 133 例发病时间<6 小时的幕上脑出血患者。所有患者均行基线及 24 小时 CT 扫描测量血肿体积,并进行 CT 血管造影(CTA)以检测斑点征。我们将 uHG 定义为基线血肿体积/发病至影像学检查时间的关系,血肿增长(HG)定义为 24 小时血肿扩大>33%或>6 mL,早期神经功能恶化(END)定义为 NIH 卒中量表评分增加≥4 分或 24 小时内死亡,预后不良定义为 3 个月改良 Rankin 量表评分>2 分。
斑点征患者 uHG 明显更快(p<0.001),HG 患者(p=0.021)、END 患者(p<0.001)、3 个月死亡率(p<0.001)和预后不良患者(p<0.001)也更快。uHG 提高了基线血肿体积预测 END(敏感性 93.1% vs 82.8%,特异性 85.3% vs 82.4%)和 3 个月死亡率(敏感性 77.5% vs 70%,特异性 87.9% vs 84.6%)的准确性。uHG>10.2 mL/h 是 HG(比值比[OR]3.55,95%置信区间[CI]1.39-9.07,p=0.008)、END(OR 70.22,95% CI 14.63-337.03,p<0.001)、3 个月死亡率(OR 16.96,95% CI 5.32-54.03,p<0.001)和预后不良(OR 6.19,95% CI 1.32-28.98,p=0.021)的最强预测因素。
uHG 是一种强大且易于使用的工具,可提高急性脑出血患者 HG 和结局的预测准确性。